Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.
about
Mutational analysis of oculocutaneous albinism: a compact reviewPromising new treatments for psoriasisNew era of biologic therapeutics in atopic dermatitisInteractions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.Cutaneous and visceral leishmaniasis during anti-TNFα therapy.Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implicationsUse of biologic agents in combination with other therapies for the treatment of psoriasisAnnual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.Antidrug antibodies in psoriasis: a systematic review.A Real-World Study to Assess the Effectiveness of Itolizumab in Patients with Chronic Plaque Psoriasis.Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015.Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis.The challenge of treating orphan disease.Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.NKG2C, HLA-E and their association with psoriasisUnique topics and issues in rheumatology and clinical immunology.Safety of biologics in psoriasis.Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2).Healthcare resource utilization, healthcare costs and dose escalation in psoriasis patients initiated on ustekinumab versus adalimumab: a retrospective claim study.Assessment and monitoring of biologic drug adverse events in patients with psoriasis.Psoriasis
P2860
Q21284502-5034B5E2-4D84-4D6F-B180-77B7A60FAFC9Q24598008-51292BE4-DA18-4D03-A7E8-314DC7ACAD3AQ27001941-9D0C7036-C260-42D3-8BF1-49E434F828E1Q30251957-5102C05D-FEFA-4F2F-9A1F-501A144512DEQ30275445-77EC16C2-3F51-4DDD-B979-2378EC1DE2BAQ34099814-5866EB59-ACD3-4657-9506-50125DE975DAQ34553755-627A57FF-6E9B-406F-854B-B97A42584352Q34944668-FA47DB66-0C39-4001-8BDB-ACAB7508CC95Q36569959-585C3EE3-35EA-40BB-9ACD-600DBAA51D60Q36628064-D774A16E-814F-4A94-9CA3-E61A67B1298FQ36923535-661D7CBD-E77D-4A45-8A93-28A49DB8D169Q38151757-32743448-F502-4E28-909E-33D622757510Q38650265-14B4FF7A-65EB-4AFC-B28A-5B7C5356A420Q38966596-1FA9F369-CE9D-45BD-AB51-7F11B2CE0C9FQ38969036-BD26C7B2-BB18-49C3-A7DF-5ADE406FFCB9Q39098238-1D3644C2-E8B2-4291-B972-B2AA93839A7CQ40060286-279738A9-2DB3-44EF-8FAF-CD875705D729Q42426824-00164E79-CA87-46E2-B7A5-9822F444C0D5Q46941311-8F52A7EF-4852-428F-ACF8-2A91B1F43859Q48144965-B058AF18-91F7-4C6B-A4C9-49ED4CF17EDBQ51037967-88BC45E8-5F2A-4078-9077-DF4DB9802553Q51362052-B1735809-F5AC-4547-8D29-43A6AA64C29BQ55153984-2B9C6625-30BB-48EC-A307-750FF94A2A8FQ58235909-02B5AB4E-2C1B-41AB-8445-26E96EC3CB3A
P2860
Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@ast
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@en
type
label
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@ast
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@en
prefLabel
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@ast
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@en
P2093
P2860
P1476
Biologic therapies in the trea ...... de to tuberculosis monitoring.
@en
P2093
Heidi Goodarzi
Lisa N Wehrli
Miki Shirakawa Garcia
Raja K Sivamani
Siba P Raychaudhuri
P2860
P2888
P304
P356
10.1007/S12016-012-8301-7
P577
2013-04-01T00:00:00Z
P6179
1029145672